Skip to main content
Clinical Trials/NCT05835817
NCT05835817
Recruiting
Not Applicable

Magnetoencephalography by Optical Pumping Magnetometer

Centre Hospitalier Universitaire, Amiens1 site in 1 country70 target enrollmentApril 11, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Magnetoencephalography
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrollment
70
Locations
1
Primary Endpoint
Signal to noise ratio of the MEG OPM
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

MagnetoEncephaloGraphy (MEG) is a method of recording brain activity with high temporal resolution and good spatial resolution, compared to current recording techniques such as ElectroEncephaloGraphy (EEG). The main limitation of MEG is its cost due to the sensors used, the Super Quantum Interference Devices (SQUID). These require a complex infrastructure from an instrumentation point of view to operate, requiring liquid helium, most often at a loss, at increasing cost. Optical Pumping Magnetometers (OPM) type sensors represent a promising alternative to SQUIDs sensors, especially since they do not require helium cooling.

The purpose of this project is to Identify biomarkers in Magnetoencephalography of normal brain development in healthy adults, premature and term newborns from "a priori" obtained by the classical technique of High Resolution EEG performed.

Registry
clinicaltrials.gov
Start Date
April 11, 2023
End Date
April 2026
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • For healthy adult volunteers
  • Age between 18 and 65
  • No pathology, no treatment
  • No toxicant intake
  • For term newborns
  • Child between 38 and 42 weeks gestational age on the day of registration
  • No pathology, no treatment
  • For children born prematurely
  • Child between 28 and 36 weeks gestational age on the day of registration
  • No pathology, no treatment apart from routine care related to prematurity

Exclusion Criteria

  • Subject and Patients "not compatible" MEG. Wearers of prosthesis or pacemaker likely to generate artefacts interfering with the measurement. There is no danger to the subject, but the measurement itself may be impossible.
  • Patients who cannot stand to stand still for a few minutes.
  • Newborn on ventilatory assistance or infusion
  • Newborn baby not meeting the age criteria

Outcomes

Primary Outcomes

Signal to noise ratio of the MEG OPM

Time Frame: 1 day

Signal to noise ratio of the MEG OPM is in dB

Signal to noise ratio of HR EEG

Time Frame: 1 day

Signal to noise ratio of HR EEG is in dB

Number of dB between Signal to noise ratio of the MEG OPM and Signal to noise ratio of HR EEG

Time Frame: 1 day

Study Sites (1)

Loading locations...

Similar Trials